Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ELANE | P08246 | 19/20 | 1.00 |
| ▸ | NPC1 | O15118 | 1/20 | 0.60 |
| ▸ | RAB9A | P51151 | 1/20 | 0.60 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29444197 | 1.00 | ELANE (1.00) | ELANENPC1RAB9A | |
| SCHEMBL12352090 | 0.79 | ELANE (1.00) | ELANENPC1RAB9A | |
| SCHEMBL272287 | 0.79 | ELANE (0.81) | ELANENPC1RAB9A | |
| SCHEMBL12352014 | 0.79 | ELANE (0.66) | ELANENPC1RAB9A | |
| SCHEMBL8795054 | 0.78 | ELANE (0.63) | ELANENPC1RAB9A | |
| SCHEMBL4117968 | 0.77 | ELANE (1.00) | ELANENPC1RAB9A | |
| SCHEMBL28961941 | 0.77 | ELANE (0.74) | ELANENPC1RAB9A | |
| SCHEMBL757536 | 0.77 | ELANE (0.72) | ELANE | |
| SCHEMBL15267924 | 0.76 | ELANE (0.61) | ELANENPC1RAB9A | |
| SCHEMBL12351952 | 0.76 | ELANE (0.61) | ELANENPC1RAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 750 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260146144-A1 | SYNERGISTIC STABILIZER COMPOSITIONS AND METHODS FOR USING SAME FOR PROTECTING ORGANIC MATERIALS FROM UV LIGHT AND THERMAL DEGRADATION | CYTEC INDUSTRIES INC. (US) | 2026-05-28 | — | — | US | claimed |
| EP-4605460-A1 | SYNERGISTIC STABILIZER COMPOSITIONS AND METHODS FOR USING SAME FOR PROTECTING ORGANIC MATERIALS FROM UV LIGHT AND THERMAL DEGRADATION | Cytec Industries Inc. (US) | 2025-08-27 | — | — | EP | claimed |
| CN-120092045-A | Synergistic stabilizer composition and method for protecting organic material from UV rays and thermal degradation using the same | 塞特工业公司 | 2025-06-03 | — | — | CN | claimed |
| WO-2025099143-A1 | COMPOSITIONS FOR STABILIZING POLYMERIC MATERIALS AGAINST UV LIGHT THERMAL AND GAS FADING DEGRADATION | CYTEC INDUSTRIES INC. (US) | 2025-05-15 | — | — | WO | claimed |
| WO-2025099141-A1 | STABILIZING COMPOSITIONS FOR POLYMERIC MATERIALS | CYTEC INDUSTRIES INC. (US) | 2025-05-15 | — | — | WO | claimed |
| WO-2025056330-A1 | STABILIZED POLYMER COMPOSITIONS WITH IMPROVED COLOR RESISTANCE | CYTEC INDUSTRIES INC. (US) | 2025-03-20 | — | — | WO | claimed |
| US-12227635-B2 | Stabilizer compositions and methods for using same for protecting polymeric organic materials from UV light and thermal degradation | CYTEC INDUSTRIES INC. (US) | 2025-02-18 | — | — | US | claimed |
| EP-4363506-A1 | COMPOSITIONS AND METHODS FOR PROTECTING COATINGS FROM THE DELETERIOUS EFFECTS OF EXPOSURE TO UV-C LIGHT | Cytec Industries Inc. (US) | 2024-05-08 | — | — | EP | claimed |
| WO-2024083872-A1 | SYNERGISTIC STABILIZER COMPOSITIONS AND METHODS FOR USING SAME FOR PROTECTING ORGANIC MATERIALS FROM UV LIGHT AND THERMAL DEGRADATION | CYTEC INDUSTRIES INC. (US) | 2024-04-25 | — | — | WO | claimed |
| CN-115636795-B | Preparation method of quinazolinone derivative containing thiobenzamide structure and composition thereof, and application of quinazolinone derivative and composition thereof in preventing and treating kiwi fruit canker | 贵州理工学院 | 2024-04-05 | — | — | CN | claimed |
| US-8680272-B2 | 3-arylethynyl substituted quinazolinone compounds | COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) | 2014-03-25 | — | — | US | claimed |
| US-20130317221-A1 | 3-ARYLETHYNYL SUBSTITUTED QUINAZOLINONE COMPOUNDS | COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) | 2013-11-28 | — | — | US | claimed |
| WO-2012111017-A1 | 3-ARYLETHYNYL SUBSTITUTED QUINAZOLINONE COMPOUNDS | CONCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) | 2012-08-23 | — | — | WO | claimed |
| EP-1205502-B1 | Polyisocyanate polyaddition products containing cyclic imino esters | BASF AG (DE) | 2005-08-17 | — | — | EP | claimed |
| EP-1205502-A1 | Polyisocyanate polyaddition products containing cyclic imino esters | BASF AKTIENGESELLSCHAFT (DE) | 2002-05-15 | — | — | EP | claimed |
| JP-8019438-B2 | — | — | 1996-02-28 | — | — | JP | claimed |
| EP-0332294-B1 | BLEACH ACTIVATORS IN DETERGENT COMPOSITIONS | BP Chemicals Limited (GB) | 1992-08-05 | — | — | EP | claimed |
| US-4966723-A | COMPRISING SURFACTANTS, PRECURSOR OF PEROXY COMPOUND, BLEACH ACTIVATOR, SUDS SUPPRESSING AGENT, AND DETERGENT BUILDER; BLEACHING AT LOW TEMPERATURES | BP CHEMICALS LIMITED (GB) | 1990-10-30 | — | — | US | claimed |
| EP-0332294-A2 | Bleach activators in detergent compositions | BP Chemicals Limited (GB) | 1989-09-13 | — | — | EP | claimed |
| WO-1989007639-A1 | BLEACH ACTIVATORS IN DETERGENT COMPOSITIONS | BP CHEMICALS LIMITED (GB) | 1989-08-24 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130317221-A1 | 3-ARYLETHYNYL SUBSTITUTED QUINAZOLINONE COMPOUNDS | NQO2, H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16, NQO1 | ELANE 3859/4885NPC1 1492/4885RAB9A 1134/4885 |
| US-20260146144-A1 | SYNERGISTIC STABILIZER COMPOSITIONS AND METHODS FOR USING SAME FOR PROTECTING ORGANIC MATERIALS FROM UV LIGHT AND THERMAL DEGRADATION | RAD52, XRCC6, RAD23B | ELANE 2476/4885NPC1 3737/4885RAB9A 4242/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.